,

Luke A Schwerdtfeger1, Federico Montini1,2, Martina Antonini Cencicchio2

  • 1Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

概括

在渐进的多发性硬化症患者中发现了质纤维酸蛋白 (GFAP) 的较高水平,这表明它可能是疾病恶化的预后生物标志物.